Breaking business news out of California a few weeks ago turned out to be a big Oklahoma story, although for Oklahomans, the news was sort of like losing your keys only to later discover them in their usual spot.

The big news involved San Francisco-based Crescendo Bioscience, which was acquired in a $270 million deal by Myriad Genetics of Salt Lake City.

Nowhere in the Feb. 4 news release that announced the deal were there mentions of Oklahoma, Riley Genomics or Mike Centola, Ph.D. Yet all three are central to the story.

Read the full story on NewsOK.